Close
Nordic 9Nordic 9

Borregaard (investor - Corporate Investor)

Norway borregaard.com
See something wrong or missing? Let us know
Offices:Sarpsborg

Borregaard is a Norwegian company, established in 1889 in the southeastern town of Sarpsborg in Østfold county. Its main products were traditionally pulp and paper.

Average round investment:27.67M USD
Average number per year:1.0
Distribution: 2025 (1)2024 (1)2023 (1)2021 (1)
Portfolio companies: Norway AlginorDenmark Kaffe Bueno ApSAustria Lignovations
Mostly invests in: Norway Norway (2) Manufacturing (4)
See the entire list

Showing 3 of 4 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Borregaard

Name Criteria
United States AbbVie Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
China Zhejiang NHU
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Agriculture
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom 4BIO Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Cargill
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Agriculture
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Denmark Sunstone Life Science Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
Switzerland Swisscanto Invest
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Agriculture
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
United States TriplePoint Capital
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Agriculture, Food Waste, Social Responsibility
  • Similar business models: B2B
  • Common investees countries: Norway, Denmark
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
Netherlands Aqua-Spark
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Agriculture
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Leafy Tunnel
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Agriculture, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States B Capital
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Agriculture, Pharma
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.1
  • Active last 12 months: Yes
Top